NICE final guidance confirms approval of new treatment for advanced bowel cancer patients in England and Wales
Wednesday 25 September 2024
We’re thrilled to see the news that the National Institute for Health and Care Excellence (NICE) has approved the use of trifluridine/tipiracil (Lonsurf) with bevacizumab (Avastin) for eligible patients.